Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, A. J. A.
Right arrow Articles by Gregory, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, A. J. A.
Right arrow Articles by Gregory, J. F.
© 2005 The American Society for Nutritional Sciences J. Nutr. 135:619-623, March 2005


Nutritional Models

Differential Kinetic Behavior and Distribution for Pteroylglutamic Acid and Reduced Folates: a Revised Hypothesis of the Primary Site of PteGlu Metabolism in Humans1

Anthony J. A. Wright2, Paul M. Finglas, Jack R. Dainty, Caroline A. Wolfe, David J. Hart, Dawn M. Wright and Jesse F. Gregory*

Nutrition Department, Institute of Food Research, Norwich NR4 7UA, United Kingdom; and * Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 32611-0370

2To whom correspondence should be addressed. E-mail: tony.wright{at}bbsrc.ac.uk.

Single 13C6-labeled doses of pteroylmonoglutamic acid (PteGlu: 634 nmol; n = 14), (6S-)5-formyltetrahydrofolic acid (431–569 nmol; n = 16), or [15N1–7]-intrinsically labeled spinach (mainly 5-methyltetrahydrofolate) (588 nmol; n = 14) were fed to fasting adult volunteers. Plasma-labeled 5-methyltetrahydrofolic acid responses were monitored for 8 h. There was a slower rate of increase in plasma-labeled 5-methyltetrahydrofolic acid and longer time to peak (171 ± 9 min; mean ± SEM) following an oral dose of [13C6]PteGlu than either [13C6]5-formyltetrahydrofolic acid (54 ± 10 min) or [15N1–7]spinach folate (60 ± 13 min) suggesting saturated metabolic capacity for the biotransformation of PteGlu. Mathematical modeling generated a significantly higher mean "apparent absorption" for 5-formyltetrahydrofolic acid (38%) and spinach folate (44%) than for PteGlu (24%). The high "relative absorption" of reduced folates to PteGlu was unexpected given that PteGlu itself, from 14C-tracer mass balance experiments, is almost completely absorbed. Although it is ubiquitously accepted that a physiological dose of PteGlu is reduced and methylated in the epithelial cells of the small intestine, and that essentially only 5-methyltetrahydrofolic acid is exported into the hepatic portal vein (HPV), as is the case for absorbed reduced 1-carbon-substituted folates, modeling indicated greater liver sequestration when PteGlu was used as the test dose, suggesting that PteGlu enters the HPV unaltered and that the liver is the primary site of initial metabolism. Because of the observed differential plasma response and the hypothesized difference in the site of initial metabolism, the historical use of PteGlu as a "reference folate" in studies of folate bioavailability is seriously questioned.


KEY WORDS: • pteroylmonoglutamic acid • folate • absorption • isotopes • modeling




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. W. Bailey and J. E. Ayling
From the Cover: The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake
PNAS, September 8, 2009; 106(36): 15424 - 15429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Aufreiter, J. F Gregory III, C. M Pfeiffer, Z. Fazili, Y.-I. Kim, N. Marcon, P. Kamalaporn, P. B Pencharz, and D. L O'Connor
Folate is absorbed across the colon of adults: evidence from cecal infusion of 13C-labeled [6S]-5-formyltetrahydrofolic acid
Am. J. Clinical Nutrition, July 1, 2009; 90(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T.-T. Kao, K.-C. Wang, W.-N. Chang, C.-Y. Lin, B.-H. Chen, H.-L. Wu, G.-Y. Shi, J.-N. Tsai, and T.-F. Fu
Characterization and Comparative Studies of Zebrafish and Human Recombinant Dihydrofolate Reductases--Inhibition by Folic Acid and Polyphenols
Drug Metab. Dispos., March 1, 2008; 36(3): 508 - 516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. R Dainty, N. R Bullock, D. J Hart, A. T Hewson, R. Turner, P. M Finglas, and H. J Powers
Quantification of the bioavailability of riboflavin from foods by use of stable-isotope labels and kinetic modeling
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1557 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Verwei, A. P. Freidig, R. Havenaar, and J. P. Groten
Predicted Serum Folate Concentrations Based on In Vitro Studies and Kinetic Modeling are Consistent with Measured Folate Concentrations in Humans
J. Nutr., December 1, 2006; 136(12): 3074 - 3078.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Chanson, T. Sayd, E. Rock, C. Chambon, V. Sante-Lhoutellier, G. Potier de Courcy, and P. Brachet
Proteomic Analysis Reveals Changes in the Liver Protein Pattern of Rats Exposed to Dietary Folate Deficiency
J. Nutr., November 1, 2005; 135(11): 2524 - 2529.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by American Society for Nutrition